A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience
Vincenzo Russo(University of Catania), Antonio D’Onofrio(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Anna Rago(University of Campania "Luigi Vanvitelli"), Gerardo Nigro(University of Campania "Luigi Vanvitelli"), Lucia Napoli(Ospedale Monaldi), Valter Bianchi(Ospedale Monaldi), Filipo Vecchione, Berardo Sarubbi(Parthenope University of Naples), Vincenzo Tavoletta(Ospedale Monaldi), Paolo Calabrò(University of Campania "Luigi Vanvitelli"), Ciro Cavallaro(Ospedale Monaldi), Stefano De Vivo(Ospedale Monaldi)
Cited by 22
Related Papers
Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension
|International Journal of Cardiology|2013|242
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry
|Cardiovascular Diabetology|2022|206
Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension
|CHEST Journal|2019|147
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry
|Pharmacological Research|2022|146
Enhanced electron screening in d(d,p)t for deuterated metals
|The European Physical Journal A|2004|144